•
Shanghai-based ClinBrain, a clinical data repository (CDR) and medical big data services provider, together with the National Clinical Research Center for Geriatric Diseases (WCH), announced the establishment of a “joint laboratory of geriatric information platform.” The two will work together on clinical research applications, the construction of a high-quality clinical…
•
Swiss giant Roche’s (SWX: ROG) China unit and Roche Diagnostics’ China unit entered into a cooperation memorandum of understanding (MoU) with Shanghai’s Class 3A Zhongshan Hospital, a major teaching hospital affiliated to China’s National Health Commission. The three entities will collaborate on clinical studies in cancer and other diseases, create…
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. struck a partnership with China-based Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd (CTTQ), a subsidiary of Sino Biopharmaceutical Ltd (HKG: 1177). The two will work together on the development of small-molecule drugs in the liver disease field. No financial details were disclosed. AI…
•
A joint Singapore-UK-Hong Kong research team has published details of an AI-based deep learning model that will help the early detection of Alzheimer’s disease using retinal photographs. The team trained a model by enrolling 648 people with Alzheimer’s and 3,240 without, taking over 12,000 retinal photographs. The model achieved an…
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with China-based CK Life Sciences to develop an AI cancer vaccine research and development (R&D) platform. The collaboration aims to leverage the respective strengths of both companies to advance the development of AI-driven cancer vaccines. Financial details of the…
•
The Zhangjiang AI New Drug R&D Alliance has welcomed new participants, including Regor Therapeutics, Roche, Hengrui Pharmaceuticals, Wuxi Biologics, LianBio, Baidu, Ainnocence, Galixir, Nutshell Therapeutics, Infinite Intelligence Pharma, and more. This expansion marks a significant step in enhancing the collaborative research efforts within the alliance. Alliance OverviewThe joint effort, initiated…
•
Subtle Medical, an Artificial Intelligence (AI)-empowered medical imaging company based in Guangdong, has reportedly raised “tens of millions” of US dollars in a Series B financing round. The round was led by Eastern Bell Capital and Primavera Venture Partners, with contributions from Fusion Fund, 3E Bioventures, Banyan Pacific Capital, Delta…
•
China-based HitGen Inc. (SHA: 688222) has announced a partnership with compatriot firm Guangzhou AIChemEco. The collaboration aims to advance the development and application of automated high-throughput synthesis technology, project undertaking and delivery, and the design and construction of a new compound library. Financial details of the partnership were not disclosed.…
•
Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company based in Hong Kong, has announced a multi-year, multi-target strategic research collaboration with French pharmaceutical major Sanofi. The partnership aims to leverage Insilico Medicine’s AI platform, Pharma.AI, to advance drug development candidates for up to six new targets. Collaboration DetailsUnder the…
•
US major Honeywell (NASDAQ: HON) has announced a partnership with China-based Tonghua Anruite Biopharmaceutical Co., Ltd at the 5th China International Import Expo (CIIE). The collaboration aims to delve into smart manufacturing and digital transformation, focusing on building a digital innovation system to enhance the smart upgrade of pharmaceutical industry…
•
China-based XtalPi, Inc. has announced a research collaboration with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to deliver chemical matter with validated binding affinities and desirable property profiles. The collaboration was facilitated by Johnson & Johnson Innovation LLC. Collaboration DetailsUnder the agreement, XtalPi will…
•
China’s Shenzhen Salubris Pharmaceuticals Co., Ltd (SHE: 002294) has entered into a partnership with compatriot firm Shenzhen Alpha Molecular Technology Co., Ltd to enhance the artificial intelligence (AI)-empowered research and development of obesity drugs. The collaboration aims to leverage the combined strengths of both companies in the field of drug…
•
Shanghai-based ClinBrain, a leading clinical data repository (CDR) and medical big data services provider, has reportedly secured RMB 200 million (USD 27.5 million) in a Series C financing round. The round was led by Legend Capital, with participation from the Shanghai Prosperity Fund. The company plans to use the funds…
•
New Jersey-based Accutar Biotechnology Inc., which is heavily backed by Chinese funds, has announced the first patient dosing in a Phase I trial for AC0682, an orally bioavailable chimeric degrader molecule targeting the ERα protein. The molecule, which previously entered a Phase I study in the US, is the firm’s…
•
China-based clinical research SaaS service provider AlphaLife Sciences has reportedly raised “tens of millions” of US dollars in a Series A+ financing round. The round was led by Hankang Capital, with participation from B Capital. The proceeds will be used to further develop and expand the company’s next-generation clinical study…
•
The National Medical Products Administration (NMPA) has approved the marketing of Beijing Union Strong Technology Co., Ltd’s intracranial aneurysm surgical planning software. This approval marks a significant advancement in the field of neurointerventional surgery, offering enhanced planning capabilities for aneurysm treatments. Software Features and FunctionalityThe product consists of an application…
•
Zhejiang-based SprintRay Co., a one-stop digital chair side solution provider for dental institutions, has reportedly raised over USD 100 million in a Series D financing round. The round was led by SoftBank Vision Fund 2, with contributions from Yiheng Capital and ZWC Partners, alongside existing investors CDBI Partners and Marathon…
•
Great Bay Bio (GBB), a Hong Kong-based biotechnology firm, announced the completion of a USD 15 million pre-Series B financing round. The funding round was led by Tiger Med’s Tiger Jade Capital, with participation from an unnamed “top life science MNC,” AEF Greater Bay Area Fund (managed by Gobi Partners…
•
Shanghai-based Lianren Digital Health has forged a strategic partnership with the People’s Government of Ningbo Municipality, announced at the World Digital Economy Conference 2022. The collaboration aims to enhance Ningbo’s healthcare digital infrastructure and data utilization, with no financial terms disclosed.Partnership Goals The alliance will focus on three pillars:Upgrading health…
•
China’s HitGen Inc. (SHA: 688222) announced a strategic research collaboration between its wholly owned subsidiary, Vernalis Research, and U.S.-based Unison Medicines Inc., targeting an undisclosed bacterial pathogen previously deemed “undruggable.” The partnership leverages Vernalis’ drug discovery expertise to design small-molecule therapies, with Unison funding all R&D activities and sharing downstream…